Pericytes contribute to pulmonary vascular remodeling via HIF2a signaling. EMBO reports Kim, H., Liu, Y., Kim, J., Kim, Y., Klouda, T., Fisch, S., Baek, S. H., Liu, T., Dahlberg, S., Hu, C. J., Tian, W., Jiang, X., Kosmas, K., Christou, H. A., Korman, B. D., Vargas, S. O., Wu, J. C., Stenmark, K. R., Perez, V. d., Nicolls, M. R., Raby, B. A., Yuan, K. 2024

Abstract

Vascular remodeling is the process of structural alteration and cell rearrangement of blood vessels in response to injury and is the cause of many of the world's most afflicted cardiovascular conditions, including pulmonary arterial hypertension (PAH). Many studies have focused on the effects of vascular endothelial cells and smooth muscle cells (SMCs) during vascular remodeling, but pericytes, an indispensable cell population residing largely in capillaries, are ignored in this maladaptive process. Here, we report that hypoxia-inducible factor 2a (HIF2a) expression is increased in the lung tissues of PAH patients, and HIF2a overexpressed pericytes result in greater contractility and an impaired endothelial-pericyte interaction. Using single-cell RNAseq and hypoxia-induced pulmonary hypertension (PH) models, we show that HIF2a is a major molecular regulator for the transformation of pericytes into SMC-like cells. Pericyte-selective HIF2a overexpression in mice exacerbates PH and right ventricular hypertrophy. Temporal cellular lineage tracing shows that HIF2a overexpressing reporter NG2+ cells (pericyte-selective) relocate from capillaries to arterioles and co-express SMA. This novel insight into the crucial role of NG2+ pericytes in pulmonary vascular remodeling via HIF2a signaling suggests a potential drug target for PH.

View details for DOI 10.1038/s44319-023-00054-w

View details for PubMedID 38243138

View details for PubMedCentralID 9199463